Thursday, April 28, 2011

Lilly wins in Eli Lilly and Company v. Wockhardt Limited, et al. over duloxetine

The court order in SD Ind requires that the remaining defendants not make generic Cymbalta during the patent term and that they tell the FDA that they are no longer seeking approval for a generic duloxetine product during the patent term.


Post a Comment

<< Home